Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

Dry, red, burning, irritated eyes are one of the most common reasons for visits to the eye doctor, but discomfort isn’t the ...

Members of Citryll’s Scientific Advisory Board include: ...

Swiss pharma giant Roche Holding AG (RHHBY) reported sales of CHF 30.9 billion for the first half of 2025, up 4% year over ...

Inaugural 'Innovation Catalyst' event empowers innovators at UConn Health to transform their exciting research ideas into ...

Selective JAK/ROCK Kinase Inhibitor for the Treatment of Immune- Mediated Diseases (POIR.01.01.01-00-0382/16). Despite ...

What kinds of treatments are available to combat dry eyes? Since I turned 55, my eyes have become increasingly dry and ...

Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to ...